P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example

Author： Mégarbane B.   Alhaddad H.  

Publisher： Oxford University Press

ISSN： 0007-0912

Source： BJA: British Journal of Anaesthesia, Vol.110, Iss.5, 2013-05, pp. : 842-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Buprenorphine-induced respiratory depression and involvement of ABCB1 SNPs in opioid-induced respiratory depression in paediatrics

By Niesters M.   Overdyk F.   Smith T.   Aarts L.   Dahan A.  

BJA: British Journal of Anaesthesia, Vol. 110, Iss. 5, 2013-05 ,pp. : 842-843

Oxford University Press

Access to resources Recommend Favorite

Development of a Risk Index for Serious Prescription Opioid‐Induced Respiratory Depression or Overdose in Veterans’ Health Administration Patients

By  

PAIN MEDICINE, Vol. 16, Iss. 8, 2015-08 ,pp. : 1566-1579

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversal of opioid‐induced respiratory depression by BK‐channel blocker GAL021: A pharmacokinetic‐pharmacodynamic modeling study in healthy volunteers

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 641-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?

By Bhupal Hardeep K  

British Journal of General Practice, Vol. 62, Iss. 595, 2012-02 ,pp. : 68-69

Royal College of General Practitioners

Access to resources Recommend Favorite

Risk Predictors of Opioid‐Induced Critical Respiratory Events in Children: Naloxone Use as a Quality Measure of Opioid Safety

By  

PAIN MEDICINE, Vol. 15, Iss. 12, 2014-12 ,pp. : 2139-2149

John Wiley & Sons Inc

Access to resources Recommend Favorite